Clinical Trial Update: Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

View source ↗

Summary

A cohort-study analysis evaluating the incidence and risk factors of CMV reactivation in patients receiving CAR-T cell therapy for relapse of acute leukemia or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Cytomegalovirus Infection
• Leukemia

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cytomegalovirus Infections, Acute Leukemia | Status: RECRUITING